Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Development and implementation of microsimulation models of neurological conditions.
Association of IL-23 and its receptor gene single nucleotide polymorphisms with Multiple Sclerosis in Chinese Southern Population.
Causes and Consequences of MicroRNA Dysregulation in Neurodegenerative Diseases.
MyelStones: the executive roles of myelin basic protein in myelin assembly and destabilization in multiple sclerosis.
Proteomic analysis for early neurodegenerative biomarker detection in an animal model.
Grey Matter Atrophy in Multiple Sclerosis: Clinical Interpretation Depends on Choice of Analysis Method.
The Plant-Derived Chalcone 2,2',5'-Trihydroxychalcone Provides Neuroprotection against Toll-Like Receptor 4 Triggered Inflammation in Microglia.
Behavioral and monoamine perturbations in adult male mice with chronic inflammation induced by repeated peripheral lipopolysaccharide administration.
Cerebrospinal fluid interleukin-6 in central nervous system inflammatory diseases.
Evidence of aquaporin involvement in human central pontine myelinolysis.
Uptake of environmental toxicants by the locus ceruleus: A potential trigger for neurodegenerative, demyelinating and psychiatric disorders.
Correction: Predicting Relapsing-Remitting Dynamics in Multiple Sclerosis Using Discrete Distribution Models: A Population Approach.
Conclusion: National incidence and risk factor assessments may become a basis for the evaluation of prevention trials - prospects from the Third Nordic MS Symposium.
Adjudin - a Male Contraceptive with Other Biological Activities.
Anti-aquaporin-4 autoantibodies in systemic lupus erythematosus persist for years and induce astrocytic cytotoxicity but not CNS disease.
Phosphorylation and linear ubiquitin direct A20 inhibition of inflammation.
Review of daclizumab and its therapeutic potential in the treatment of relapsing-remitting multiple sclerosis.
The glutathione S-transferase T1 deletion is associated with susceptibility to multiple sclerosis.
[The impact of the vitamin D in neurological diseases and neurorehabilitation: from demencia to multiple sclerosis. Part I: the role of the vitamin D in the prevetion and treatment of multiple sclerosis].
Cholesterol and markers of cholesterol turnover in multiple sclerosis: relationship with disease outcomes.
Optic neuritis with positive HLA-B27: Characteristic phenotype in the Chinese population.
Biological role of Toll-like receptor-4 in the brain.
Natalizumab discontinuation in the increasing complexity of multiple sclerosis therapy.
Neurologic diseases of the central nervous system with pathophysiologically relevant autoantibodies - Perspectives for immunoadsorption.
Advances in the management of multiple sclerosis spasticity: recent clinical trials.

Pages